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Introduction
============

The past decade has witnessed unprecedented legalization and decriminalization of cannabis use across many states in the United States \[[@REF1]\]. However, cannabis still maintains its status as a strictly prohibited drug at the federal level \[[@REF1]\]. Marijuana is currently the most commonly used recreational drug in the United States, with \>22 million users per month \[[@REF2]\]. As of December 2018, marijuana was legal for medicinal use in thirty-three states and the District of Columbia (DC), while ten states and DC have enacted policies enabling recreational marijuana use \[[@REF3]\].

Heart failure constitutes a significant public health issue, and its estimated prevalence is \>5.7 million in the United States (US) \[[@REF4]\]. Heart failure also constitutes a huge strain on the health care system, responsible for health care costs greater than \$39 billion annually in the US \[[@REF4]\]. The lifetime risk of developing heart failure is estimated to be 20% \[[@REF4]\]. Thus, the consensus from a few published case reports and studies is that cannabis use may be associated with the development of left ventricular dysfunction and heart failure \[[@REF5]-[@REF8]\]

However, there is a dearth of systematic studies evaluating outcomes and trends of cannabis use disorder (CUD) in acute heart failure.

Based on limited data on comorbid CUD in heart failure patients, our study used Nationwide Inpatient Sample (NIS) data to determine the trends of demographic factors, in-hospital outcomes, and comorbidities for congestive heart failure (CHF) hospitalizations and cannabis use. Next, we compared in-hospital outcomes among CUD vs. non-CUD patients admitted for CHF

Materials and methods
=====================

Data source

We used the NIS data in our study and diagnostic information was obtained using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, and clinical classification (CCS) codes \[[@REF9]\].

Inclusion criteria

We identified 4,596,024 patients with a primary discharge diagnosis of CHF using ICD-9-CM codes of 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0-428.9 and 23,358 patients with co-morbid CUD using ICD-9-CM codes 304.30-304.32, and 305.2.

Variables of interest

To study the demographic trends in patients admitted for CHF with CUD from 2010-2014, we included demographic factors such as age, race, gender, household income, and primary payer status \[[@REF10]\]. We compared the baseline demographics and in-hospital outcomes-length of stay (LOS), in-hospital mortality, and total hospital costs) between CUD and non-CUD patients admitted for CHF.

Comorbidities were considered coexisting clinical conditions to CHF. For assessment of comorbidities, the Agency for Healthcare Research and Quality (AHRQ) comorbidity software was used to create binary variables \[[@REF11]\], then ICD-9 CM diagnosis codes were used to identify comorbidities. The ICD-9 CM codes used to determine the comorbid conditions are available in the appendices. We also applied discharge weights (DISCWT) to obtain a nationwide representative sample population \[[@REF10]\].

Statistical analyses

Statistical analysis was done by SPSS version 25 (IBM, Armonk, NY, US). We used the independent sample t-test and analysis of variance (ANOVA) for measuring continuous data. Pearson's chi-square test was used for categorical data. Trends were analyzed with the linear-by-linear association tests. A p-value ≤ 0.05 was used to define the statistical significance of the tests. The NIS database did not contain any personally identifiable information. Therefore, an institutional review board (IRB) approval was not needed for this study.

Results
=======

Demographics, inpatient outcomes and trends

The total number of admissions identified with a primary diagnosis of CHF over the five years was N = 4,596,024, and 0.5% (N = 23,358) of these patients had a co-diagnosis of CUD as shown in Table [1](#TAB1){ref-type="table"} below.

###### Baseline characteristics of CHF hospitalizations by comorbid CUD.

P ≤ 0.05 indicates statistical significance. CHF: congestive heart failure; CUD: cannabis use disorder; USD: United States Dollars; N: number; SD: standard deviation.

  ---------------------------------------- -------------------- --------------- --------- ------ ---------
                                           CHF, N = 4,596,024                                    
  Variable                                 Non-CUD              CUD             P-Value          
  N                                        \%                   N               \%               
  Total admissions                         4,572,666            99.5            23,358    0.5     
  Mean age at admission (SD), in years     72.77 (14.43)        49.78 (11.24)   \<0.001          
  Sex                                                                                            
  Males                                    2,296,127            50.2            18,448    79.0   \<0.001
  Females                                  2,276,092            49.8            4910      21.0   
  Race                                                                                           
  White                                    2,920,078            68.4            7111      31.9   \<0.001
  African Americans                        831,467              19.5            12,362    55.4   
  Hispanic                                 32,090               7.5             1803      8.1    
  Other                                    197,758              4.6             1034      4.6    
  Median household income, in percentile                                                         
  0--25th                                  1,481,175            33.1            11,666    51.8   \<0.001
  26th--50th                               1,184,624            26.4            5157      22.9   
  51st--75th                               1,020,324            22.8            3906      17.4   
  76th--100th                              793,574              17.7            1781      7.9    
  Primary payer                                                                                  
  Medicare                                 344,360              75.5            6505      27.9   \<0.001
  Medicaid                                 369,350              8.1             8950      38.5   
  Private                                  523,995              11.5            2488      10.7   
  Self-pay or uninsured                    147,146              3.2             4164      17.9   
  Others                                   79,127               1.7             1169      5.0     
  Comorbidities                                                                                  
  Alcohol abuse                            126,464              2.8             6075      26.0   \<0.001
  Depression                               4,555,384            10.0            2500      10.7   \<0.001
  Diabetes, without complications          1,574,996            34.4            5704      24.4   \<0.001
  Diabetes, with complications             478,489              10.5            3700      7.7    \<0.001
  Hypertension                             3,436,096            75.1            17,276    74.0   \<0.001
  Metastatic cancer                        45,995               1.0             89        0.4    \<0.001
  Renal failure                            188,1371             41.1            7153      30.6   \<0.001
  Severity of illness                                                                            
  Nil                                      221                  \<0.1           0         0.0    0.001
  Minor                                    324,608              7.1             2263      9.7    
  Moderate                                 1,680,851            36.8            9154      39.2   
  Major                                    2,566,986            56.1            11,941    51.1   
  Other hospital outcomes                                                                        
  Mean length of stay (SD), in days        5.19 (5.82)          4.62 (4.98)     0.001            
  Mean total charges in (USD)              40,730               41,642          0.08             
  In-hospital mortality                    140,878              3.1             249       1.1    \<0.001
  ---------------------------------------- -------------------- --------------- --------- ------ ---------

The proportion of total CUD admissions had an increasing trend from 0.4% (N = 3588) in 2010 to 0.7% (N = 6365) in 2014, which represents a 77.4% (P~trend~ \< 0.001) increase over the five years as shown in Table [2](#TAB2){ref-type="table"} below.

###### Trends of demographics and hospital outcomes of CUD in CHF inpatients.

P ≤ 0.05 indicates statistical significance. CHF: congestive heart failure; CUD: cannabis use disorder; USD: United States Dollars; SD: standard deviation.

  ------------------------------------ --------------- --------------- --------------- --------------- --------------- --------------- ---------- -----------------
  Variables                            2010            2011            2012            2013            2014            Overall Total   P~trend~   Trend Direction
  No Of CUD admissions                 3588            3970            4305            5130            6365            23,358                      
  CUD admissions prevalence (%)        0.4             0.4             0.5             0.6             0.7             0.5             \<0.001    Increasing
  Age at admission                                                                                                                                 
  Mean age (SD) (in years)             48.08 (11.41)   48.93 (11.22)   50.11 (11.22)   50.25 (10.81)   50.65 (11.38)   49.78 (11.24)   \<0.001    Increasing
  Gender (%)                                                                                                                                       
  Males                                81.7            78.9            81.2            78.9            76.0            79              0.001      Decreasing
  Females                              18.3            21.1            18.8            21.1            24.0            21.0            0.001      Increasing
  Race (%)                                                                                                                                         
  Whites                               25.7            33.7            27.8            33.9            35.3            31.9            0.466      Increasing
  African Americans                    64.1            52.8            57.8            53.6            52.1            55.4            0.466      Decreasing
  Hispanics                            7.4             9.7             8.3             7.8             7.6             8.1             0.466      Increasing
  Others                               2.8             3.8             6.2             4.7             5.0             4.6             0.466      Increasing
  Income level (%)                                                                                                                                 
  0--25th percentile                   54.3            49.7            53.2            48.5            53.5            51.8            0.851      Variable
  26th--50th percentile                22.7            21.1            21.7            25.4            23.0            22.9            0.851      Variable
  51st--75th percentile                16.8            19.6            17.8            17.4            15.9            17.4            0.851      Variable
  76th--100th percentile               6.2             9.5             7.3             8.8             7.6             7.9             0.851      Increasing
  Insurance (%)                                                                                                                                    
  Medicare                             26.3            27.2            28.3            27.9            29.1            27.9            \<0.001    Increasing
  Medicaid                             34.5            35.6            36.8            36.5            45.1            38.4            \<0.001    Increasing
  Private                              13.2            11.5            10.0            10.4            9.4             10.7            \<0.001    Decreasing
  Self-pay                             20.2            19.2            18.6            19.5            14.0            17.9            \<0.001    Decreasing
  Other                                5.7             6.4             6.3             5.7             2.4             5.0             \<0.001    Variable
  Severity of Illness (%)                                                                                                                          
  Minor                                8.9             8.8             10.9            11.4            8.5             9.7             0.946      Variable
  Moderate                             39.4            37.5            41.8            39.3            38.3            39.2            0.946      Variable
  Major                                51.7            53.6            47.3            49.3            53.3            51.1            0.946      Variable
  Other hospital outcomes                                                                                                                          
  In-hospital mortality (%)            0.7             0.8             1.5             1.2             1.0             1.1             0.137      Increasing
  Mean total charges in USD            34,776          44,100          41,729          42,451          43,292          41,642          \<0.001    Increasing
  Mean length of stay (SD) (in days)   4.21 (3.58)     4.61 (4.39)     4.72 (5.30)     4.76 (5.95)     4.66 (4.91)     4.62 (4.98)     0.001      Increasing
  ------------------------------------ --------------- --------------- --------------- --------------- --------------- --------------- ---------- -----------------

The mean age of CUD patients increased significantly from 48.08 ± 11.41 years in 2010 to 49.78 ± 11.24 years (P~trend~ \< 0.001). Males (79%) constituted most of the cannabis users, but there was a significant declining trend of CUD prevalence from 81.7% in 2010 to 76.0% in 2014 (P~trend~ = 0.001). Conversely, CUD prevalence among females increased from 18.3% to 21.0% in the five years (P~trend~ = 0.001). More than half of cannabis users were African Americans, followed by Caucasians (31.9%), Hispanics (8.1%), and others (4.6%). CUD prevalence among Whites and Hispanics followed an increasing trend but followed a decreasing trend among African Americans. All race groups showed a non-statistically significant trend (P~trend~ = 0.466).

Regarding median household income in percentiles, CUD prevalence among patients below the 25th percentile, 26th to 50th percentile, and 51st to 75th percentile showed a variable trend, while CUD prevalence in the highest percentile demonstrated an increasing trend from 2010 to 2014 (P~trend~ = 0.851). Patients below the 25th percentile represented about half of the CUD admissions.

In terms of insurance status, Medicaid was the primary insurance for 38.4% of the total CUD population, while Medicare was the primary payer for 27.9%. Both Medicaid and Medicare payments had an increasing trend (P~trend~ \< 0.001). Private insurance and self-pay mode of payment followed statistically significant down-trend payments from 13.2% to 9.4% and 20.2% to 14% over the five years (P~trend~ \< 0.001) respectively.

Cannabis users with major morbidity made up 51.1% of the total CUD population, and there was a non-statistically significant variable trend from January 2010 to December 2014 (P~trend~ = 0.946). In-hospital mortality (1.1% vs. 3.1%), was lower, and mean LOS in days were shorter in CUD patients compared to the non-CUD cohort (P \< 0.001) and (P = 0.001) respectively. There was a non-statistical difference in total hospital charges between CUD and non-CUD patients (P = 0.08).

In-hospital mortality among CUD patients followed a non-statistically significant trend from 0.7% to 1.1% from 2010 to 2014 (P~trend~\< 0.137), but there were a significant trend increase from 2010 to 2014 for both LOS in days (P~trend~ = 0.001) and total hospital charges (P~trend~\< 0.001).

Comorbidities and trends

Comorbidities of diabetes, hypertension, renal failure, and metastatic cancer were less prevalent among cannabis users as shown in Figure [1](#FIG1){ref-type="fig"} below.
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At the same time, alcohol abuse and depression were more prevalent among CUD patients. Alcohol abuse showed a significant decreasing trend from 2010 to 2014 (P~trend~ \< 0.001) as shown in Table [3](#TAB3){ref-type="table"} below

###### Trends of comorbidities associated with CUD in CHF patients.

p ≤ 0.05 indicates statistical significance. CHF: congestive heart failure; CUD: cannabis use disorder.

  -------------------------------- ------- ------- ------- ------- ------- ------- ----------- -----------------
  Comorbidities                    2010    2011    2012    2013    2014    Total   P ~trend~   Trend Direction
  Alcohol abuse                    27.1%   26.9%   27.1%   26.1%   24.0%   26.0%   \<0.001     Decreasing
  Depression                       10.4%   11.4%   10.1%   10.3%   11.2%   10.7%   0.621       Variable
  Diabetes without complications   22.1%   22.4%   26.5%   24.9%   25.2%   24.4%   \<0.001     Increasing
  Diabetes with complications      6.2%    8.1%    6.6%    8.0%    8.6%    7.7%    \<0.001     Increasing
  Hypertension                     73.9%   73.4%   74.7%   73.2%   74.5%   74.0%   0.590       Variable
  Metastatic Cancer                0.3%    0.4%    0.1%    0.8%    0.3%    0.4%    0.126       Variable
  Renal failure                    30.6%   30.6%   29.8%   30.4%   31.3%   30.6%   0.412       Stable
  -------------------------------- ------- ------- ------- ------- ------- ------- ----------- -----------------

Conversely, diabetes, with and without complications significantly increased in a linear trend from 2010 to 2014 (P~trend~ \< 0.001).

Comorbidities of hypertension (P~trend~ = 0.590), depression (P~trend~ = 0.621), and metastatic cancer (P~trend~= 0.126) showed a non-significant variable trend. Renal failure was the only comorbidity that showed a stable linear trend. 

Discussion
==========

This study considered demographic factors (age, race, gender, insurance type, household income), the severity of illness, in-hospital mortality, total hospital charges, and LOS in both cannabis users and non-users. Trends of coexisting comorbidities among CHF hospitalizations with CUD was also explored. We reported an overall prevalence of CUD among CHF inpatients as 0.5% and a significant trend of 77.4%. These findings are similar to a recent study by Charilaou et al. that reported an increase in cannabis abuse prevalence in patient populations from 0.5% to 1.3% from 2002 to 2011 \[[@REF12]\]. Our observation may be partially explained by the legalization of medical and recreational cannabis in the many U.S. states \[[@REF13],[@REF14]\], which consecutively led to an increase in the prevalence of cannabis users in the general population, and by extension increased the odds of observing them in admitted patients, including CHF hospitalizations \[[@REF12]\].

In another study of cannabis use, Kalla et al. showed that cannabis use was an independent risk predictor of heart failure \[[@REF8]\]. Evidence of this association between cannabis use and heart failure is backed by prior human and animal studies \[[@REF15]-[@REF18]\]. Three earlier studies showed that endocannabinoids acting on CB-1 receptors caused decreased myocardial contractility \[[@REF15]-[@REF17]\]. Su et al. also showed that the negative inotropy activity of CB2 agonists, independent of CB1 and CB2 receptors, causes decreased myocardial contractility \[[@REF18]\].

Our study showed that cannabis users were predominantly males (79%) with a mean age of 49.8 years. These findings are consistent with findings by Wu and colleagues in a study of the effects of marijuana use on heart failure, which reported a mean age of 50.4 years and predominance of males (78.3%) among marijuana users compared to non-users \[[@REF19]\].

Two notable findings of this study are the lower mortality rate (1.1% vs. 3.1%) and reduced LOS (4.62 vs. 5.12 days) among cannabis users compared to non-cannabis users. These results are similar to findings of a previous study that marijuana use was associated with reduced inpatient mortality (odds ratio (OR): 0.197 (0.046-0.083) p = 0.0142) and reduced LOS (4.2 ± 0.1 vs. 4.8 ± 0.2, p = 0.0038) in patients admitted for heart failure \[[@REF19]\]. We hypothesized that the lower mortality among CUD patients admitted for heart failure is due to the relatively younger age of this cohort, which makes it possible that the baseline risk of dying in these patients was less than that of non-cannabis users. Another possible explanation for the lower mortality is reduced severity of illiness among cannabis users.

A possible explanation for the reduced mean LOS among cannabis users could be a reduced severity of CHF illness. Notwithstanding these findings require further investigation in the future. This study demonstrated a statistically significant increase in LOS among cannabis users from 2010 to 2014, which we believe caused an increase in hospital charges from (\$34,776 to \$43,292). Unlike our study which did not show any significant differences in hospital costs between CUD and non-CUD patients, a prior study by Wu et al. \[[@REF19]\] demonstrated a significantly lower hospital cost among cannabis users vs. non-users. Although the reason for the above finding is largely speculative, this contrasting finding from previous observation is a significant addition to the body of literature.

Our study revealed essential differences in demographic factors between CUD and non-CUD patients admitted for CHF. Patients hospitalized for CHF with CUD were mostly younger men of African American origin and earned less than the 50th percentile household income. Like our study, it was reported by Nishimura et al. that patients hospitalized for heart failure who had a history of substance abuse were mostly males, and likely to be African American and younger \[[@REF20]\].

Alcohol abuse (74% vs. 26%) had a higher prevalence among cannabis users compared to non-CUD. Previous studies of cannabis use in the inpatient population support this finding. Charilaou et al. explored comorbidities associated with cannabis use disorder in inpatients between 2002 to 2011 using the AHRQ comorbidity indicators and reported alcohol abuse as one of the primary comorbid conditions associated with cannabis use \[[@REF12]\]. In the same study, approximately 33% of inpatient cannabis users were reported to have a history of alcohol abuse \[[@REF12]\]. Similarly, another study that reported alcohol study surveys of marijuana and other illicit drugs revealed that most marijuana users were either binge drinkers or users of other substances \[[@REF21]\]. Furthermore, Smit and Crespo studied the nutritional status of adult cannabis users and found out that cannabis users consume higher proportions of alcohol compared to non-users \[[@REF22]\]. It is worth mentioning that alcohol abuse is associated with alcoholic cardiomyopathy \[[@REF23]\], which is characterized by increased left ventricular mass, left ventricular dilation along with reduced and/or normal ventricular wall thickness \[[@REF24]\]

Alcohol abuse as a comorbidity demonstrated a statistically significant decreasing trend from 2010 to 2014. A possible explanation for this phenomenon is the "substitution effect" of alcohol with cannabis use and other illicit drugs by cannabis users \[[@REF25],[@REF26]\].

Our results showed a higher prevalence of depression among cannabis users vs. non-users (10.7% vs. 10%). Long term use of cannabis has been previously linked with depression \[[@REF27]\]. In a prior study of heart failure patients with depression, 15% of these patients were found to have substance abuse problems \[[@REF28]\].

This present study has a few limitations that should be considered when interpreting the results. Based on the administrative nature of the NIS database, there is a possibility of coding inaccuracies and classification errors. Secondly, due to the contentious legal and societal status of cannabis use, reporting of cannabis abuse is prone to underreporting bias. Based on the nature of the database, there was unavailability of patient-level information; therefore, adjustment for confounders could not be performed during analysis. Our study, being an observational study, could not assess a temporal relationship between cannabis use and CHF. The level of exposure to cannabis use could not be assessed because of the unavailability of the information in the database, so we were unable to comment on the quantity of cannabis.

Despite these limitations, the NIS database provides an invaluable population-based resource for evaluating national trends. Another strength of this study is obtained from the large sample size of the NIS data, which has enough power to determine differences between CUD and non-CUD CHF populations. Findings from our study also serve as hypotheses and a valuable reference for further research.

Conclusions
===========

Among CUD patients hospitalized for CHF, the trend for the total number of admissions, mean LOS and mean total charges increased significantly over the five-year period of study. In addition, CUD patients had less all-cause in-hospital deaths and shorter hospital stays compared to non-users. Moreover, cannabis users followed a specific demographic profile as they were mostly males, African Americans, and lower-income earners. Further in-depth research is warranted to explore a causal relationship between cannabis use and the development of heart failure
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###### ICD-9 CM codes for co-morbid conditions

  -------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  Alcohol abuse                    305.00--305.03, 303.00--303.93, 291.9, 291.89, 291.81,291.8, 291.5, 291.0--291.3
  Depression                       311, 309.1, 309.0, 301.12, 300.4.
  Diabetes without complications   648.00--648.04, 250.00--250.33, 249.00--249.31.
  Diabetes with complications      775.1, 250.40--250.93, 249.40--249.91.
  Hypertension                     642.70--642.94,642.10--642.24, 642.00--642.04, 437.2, 402.00--405.99, 401.0, 401.1, 401.9.
  Metastatic cancer                199.0--199.2, 198.0--198.89, 197.0--197.8, 196.0--196.9
  Renal failure                    586, 585.9, 585.6, 585.5, 585.4, 585.3, 404.93, 404.92, 404.13, 404.12, 404.03, 403.01, 404.02, 403.91, V56.8, V56.0-V56.32, V45.12, V45.1, V42.0.
  -------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
